Search - tctmd.com

Displaying 941 - 960 of 1159

Sort: Relevancy | Date

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Daily News

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Todd Neale

August 20, 2014

News Daily News

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

August 07, 2014

News Industry News

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

July 24, 2014

News Daily News

La Trombólisis Dirigida por Cateter para el Manejo de la TVP Aumenta las Hemorragias comparado con la Anticoagulación Estándar

L.A. McKeown

July 24, 2014

News Daily News

DVT导管溶栓术的出血风险比标准坑凝血方法高

L.A. McKeown

July 24, 2014

News Daily News

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

L.A. McKeown

July 24, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

July 17, 2014

News Daily News

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

L.A. McKeown

July 03, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

July 02, 2014

News Daily News

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Yael L. Maxwell

June 27, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

Advertisement

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

La Trombólisis Dirigida por Cateter para el Manejo de la TVP Aumenta las Hemorragias comparado con la Anticoagulación Estándar

DVT导管溶栓术的出血风险比标准坑凝血方法高

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content